您当前的位置:
首页 >
文章列表页 >
JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1
Full-length article | 更新时间:2023-08-29
    • JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1

    • JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1

    • Genes & Diseases   2023年10卷第5期
    • DOI:10.1016/j.gendis.2022.07.006    

      中图分类号:
    • 纸质出版日期:2023,

      网络出版日期:2023-9-1,

    扫 描 看 全 文

  • Junping Liu, Yutong Shi, Minmin Wu, 等. JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1[J]. Genes & Diseases, 2023,10(5). DOI: 10.1016/j.gendis.2022.07.006.

    Junping Liu, Yutong Shi, Minmin Wu, et al. JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1[J]. Genes & Diseases, 2023,10(5). DOI: 10.1016/j.gendis.2022.07.006.

  •  
  •  
查看原文

0

浏览量

0

下载量

0

CSCD

文章被引用时,请邮件提醒。
提交
工具集
下载
参考文献导出
分享
收藏
添加至我的专辑

相关文章

The journey towards physiology and pathology: Tracing the path of neuregulin 4
HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies
Mechanistic insight into lysyl oxidase in vascular remodeling and angiogenesis
LncRNA H19 mediates BMP9-induced angiogenesis in mesenchymal stem cells by promoting the p53-Notch1 angiogenic signaling axis
Defective EMC1 drives abnormal retinal angiogenesis via Wnt/β-catenin signaling and may be associated with the pathogenesis of familial exudative vitreoretinopathy

相关作者

Liang Guo
Wangjing Mu
Hongyang Luo
Jieying Zhu
Min Chen
Yan Zhao
Cheng Xing
Yating Deng

相关机构

School of Exercise and Health and Shanghai Frontiers Science Research Base of Exercise and Metabolic Health, Shanghai University of Sport
Hunan Engineering Research Center of Cell Immunotherapy for Hematopoietic Malignancies, The Second Xiangya Hospital, Central South University
Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Central South University
Department of Hematology, The Second Xiangya Hospital, Central South University
Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education
0